Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 88567 · Class II · American National Red Cross Blood Services SW Region
Key facts
| Event ID | 88567 |
|---|---|
| Recall numbers | B-0596-2021 |
| Recalling firm | American National Red Cross Blood Services SW Region |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis products, for which quality control for WBC count was not performed, were distributed. |
| Initiation date | Jul 15, 2021 |
| Report date | Sep 22, 2021 |
| Termination date | Sep 16, 2021 |
| City | Tulsa |
| State | OK |
| Country | United States |
| FEI number | 1673040 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: